Identification, validation and qualification of biomarkers for osteoarthritis in humans and companion animals: Mission for the next decade

Veterinary Journal

Volumn 185, Issue 2, 2010, Pages 95-97

  Mobasheri, Ali ^a   Henrotin, Yves ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHONDROITIN SULFATE; CLEAVAGE NEO EPITOPE; COLLAGEN TYPE 2; COLLAGEN TYPE 2 NITROGEN DIOXIDE; DENATURATION EPITOPE; DISEASE MODIFYING ANTIOSTEOARTHRITIC DRUG; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; GLUCOSAMINE SULFATE; HYALURONIC ACID; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; OPIATE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ARTICULAR CARTILAGE; BONE RADIOGRAPHY; CARTILAGE CELL; CARTILAGE DEGENERATION; CORRELATIONAL STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; JOINT RADIOGRAPHY; NONHUMAN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SYNOVITIS; ANIMAL; CAT; DOG; HORSE; METABOLISM; VALIDATION STUDY; VETERINARY;

ANIMALS; BIOLOGICAL MARKERS; CATS; DOGS; HORSES; HUMANS; OSTEOARTHRITIS; VALIDATION STUDIES AS TOPIC;

ANIMALIA;

EID: 77954029991     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.05.026     Document Type: Review

References (27)

1. Archer C.W., Francis-West P. The chondrocyte. International Journal of Biochemistry and Cell Biology 2003, 35:401-404.
2. Buckwalter J.A., Mankin H.J. Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instructional Course Lectures 1998, 47:487-504.
3. Buckwalter J.A., Martin J., Mankin H.J. Synovial joint degeneration and the syndrome of osteoarthritis. Instructional Course Lectures 2000, 49:481-489.
4. Buckwalter J.A., Mankin H.J., Grodzinsky A.J. Articular cartilage and osteoarthritis. Instructional Course Lectures 2005, 54:465-480.
5. Carney S.L., Muir H. The structure and function of cartilage proteoglycans. Physiological Reviews 1988, 68:858-910.
6. Christgau S., Garnero P., Fledelius C., Moniz C., Ensig M., Gineyts E. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001, 29:209-215.
7. Garvican E.R., Vaughan-Thomas A., Innes J.F., Clegg P.D. Biomarkers of cartilage turnover. Part 1: markers of collagen degradation and synthesis. The Veterinary Journal 2010, 185:36-42.
8. Garvican E.R., Vaughan-Thomas A., Clegg P.D., Innes J.F. Biomarkers of cartilage turnover. Part 2: non-collagenous markers. The Veterinary Journal 2010, 185:43-49.
9. Goggs R., Vaughan-Thomas A., Clegg P.D., Carter S.D., Innes J.F., Mobasheri A., Shakibaei M., Schwab W., Bondy C.A. Nutraceutical therapies for degenerative joint diseases: a critical review. Critical Reviews in Food Science and Nutrition 2005, 45:145-164.
10. Henrotin Y., Sanchez C., Balligand M. Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. The Veterinary Journal 2005, 170:113-123.
11. Henrotin Y., Addison S., Kraus V., Deberg M. Type II collagen markers in osteoarthritis: what do they indicate?. Current Opinion in Rheumatology 2007, 19:444-450.
12. Huang K., Wu L.D. YKL-40: a potential biomarker for osteoarthritis. Journal of International Medical Research 2009, 37:18-24.
13. Hunter D.J., Losina E., Guermazi A., Burstein D., Lassere M.N., Kraus V. A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials. Current Drug Targets 2010, 11:536-545.
14. Innes J.F., Clayton J., Lascelles B.D. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Veterinary Record 2010, 166:226-230.
15. Jordan J.M. Cartilage oligomeric matrix protein as a marker of osteoarthritis. Journal of Rheumatology 2004, 70:45-49.
16. Kraus V.B. Biomarkers in osteoarthritis. Current Opinion in Rheumatology 2005, 17:641-646.
17. Kraus V.B., Kepler T.B., Stabler T., Renner J., Jordan J. First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. Public Library of Science One 2010, 5:e9739.
18. Lees P. Pharmacology of drugs used to treat osteoarthritis in veterinary practice. Inflammopharmacology 2003, 11:385-399.
19. Lohmander L.S. Markers of altered metabolism in osteoarthritis. Journal of Rheumatology 2004, 70(Suppl.):28-35.
20. Muir H. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. BioEssays 1995, 17:1039-1048.
21. Poole A.R., Ionescu M., Fitzcharles M.A., Billinghurst R.C. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. Journal of Immunological Methods 2004, 294:145-153.
22. Qvist P., Christiansen C., Karsdal M.A., Madsen S.H., Sondergaard B.C., Bay-Jensen A.C. Application of biochemical markers in development of drugs for treatment of osteoarthritis. Biomarkers 2010, 15:1-19.
23. Rousseau J.C., Delmas P.D. Biological markers in osteoarthritis. Nature Clinical Practice Rheumatology 2007, 3:346-356.
24. Sipe J.D. Acute-phase proteins in osteoarthritis. Seminars in Arthritis Rheumatism 1995, 25:75-86.
25. Sutton S., Clutterbuck A., Harris P., Gent T., Freeman S., Foster N., Barrett-Jolley R., Mobasheri A. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. The Veterinary Journal 2009, 179:10-24.
26. Tseng S., Reddi A.H., Di Cesare P.E. Cartilage oligomeric matrix protein (COMP): a biomarker of arthritis. Biomarker Insights 2009, 4:33-44.
27. Williams F.M. Biomarkers: in combination they may do better. Arthritis Research and Therapy 2009, 11:130.